Cara Therapeutics (CARA) Misses Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Cara Therapeutics (CARA) Misses Q4 EPS by 2c

Janney Cuts Price Target on Cara Therapeutics (CARA) as UP is Delayed

March 11, 2016 10:12 AM EST

Janney Capital maintained a Buy rating on Cara Therapeutics (NASDAQ: CARA), and cut the price target to $18.00 (from $23.00), following the company's 4Q earnings report and conference call. The most significant development on the call was the disclosure that its December 2015 meeting with the FDA regarding its effort to develop CR845 for UP. Janney thought... More